Abstract
Background: Multimodal treatment of patients with glioblastoma multiforme (GBM) allows an increasing number of patients to survive beyond one year. On account of various neurological and psychophysiological impairments, however, these patients may not benefit in terms of quality of life (QOL). We evaluated the subjective QOL, clinical psychophysiological and cognitive functions in patients with GBM surviving 18 months after diagnosis.
Patients and methods: Thirteen patients underwent psychophysiological and psychometric measurements for central-nervous activation, habituation of skin-conductance reaction, crystallized intelligence, verbal and psychovisual memory. QOL was assessed by the symptom check-list for somatization (SCS-Score).
Results: We found various impairments such as central-nervous deactivation (n = 9) or high activation (n = 3), psychovegetative overexcitement (n = 3) or attenuation (n = 1), reduced verbal (n = 5) and/or psychovisual (n = 5) memory and loss in attention (n = 7) or concentration (n = 5). Severe physical symptoms (grade 5) were fatigue, convulsion, headache, nausea and micturition difficulties. Eleven patients expressed high satisfaction with life in general, whereas only 4 were satisfied with their general state of health. All patients were independent and 8 patients returned to work.
Conclusion: Despite various psychophysiological and cognitive impairments, subjective QOL appears mostly unaffected in this patient setting.
Similar content being viewed by others
References
Fine HA, Dear KBG, Loeffler JS et al.: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
Scott JN, Rewcastle NB, Brasher PMA et al.: Which glioblastoma multiforme patient will become a long-term survivor? A population based study. Ann Neurol 46: 1999, 183-188
Ammirati M, Vick N, Liao Y et al.: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21: 201-206, 1987
Levin VA, Leibel S, Gutin PH: Neoplasms of the central nervous system. In: deVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. 5th edn., Lippincott-Raven, Philadelphia, PA, 1997, pp 2022-2082
Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunctions following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neuro-Oncol 30: 61-69, 1996
Taylor BV, Bruckner JC, Cascino TL et al.: Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16: 2195-2201, 1998
Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28: 818-822, 1990
Archibald YM, Lunn D, Ruttan LA et al.: Cognitive functioning in long-term survivors of high grade glioma. J Neurosurg 80: 247-253, 1994
Gregor A, Cull A, Traynor E et al.: Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 41: 55-59, 1996
Scinto LFM, Daffner KR, Dressler D et al.: A potential noninvasive neurobiological test for Alzheimer's disease. Science 266: 1051-1054, 1994
Francis PT, Sims NR, Procter AW, Bowen DM: Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and impairment in Alzheimer's disease: investigative and therapeutic prospect. J Neurochem 60: 1589-1604, 1993
Grünberger J, Linzmayer L, Walter H et al.: Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillation) in patients with Alzheimer's disease. Neuropsychobiology 40: 40-46, 1999
Saletu-Zyhlarz G, Saletu B, Anderer P et al.: Nonorganic insomnia in generalized anxiety disorder. 1: Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology 36: 117-129, 1997
Saletu B, Saletu-Zyhlarz G, Anderer P et al.: Nonorganic insomnia in generalized anxiety disorder. 2: comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (‘somnium’) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods. Neuropsychobiology 36: 130-152, 1997
Gruenberger J: Psychodiagnostik des Alkoholkranken. Maudrich, Vienna, 1977
Grünberger J, Linzmayer L, Walter H et al.: Psychophysiological diagnostics in alcohol-dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency. Alcohol Alcoholism 33: 541-548, 1998
Meyers CA, Hess KR, Yung WKA, Levin VA: Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18: 646-650, 2000
Feld R: Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer 3: 23-27, 1995
Gotay CC, Korn El, McCabe MS et al.: Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84: 575-579, 1992
Grünberger J, Linzmayer L, Saletu B: Eine neue Methode zur Messung der zentralen Aktivierung: Fourier Analyse der Pupillenoszillationen bei depressiven Patienten.Wiener Klinische Wochenschrift 106: 164-170, 1994
Grünberger J, Linzmayer L, Wytek R, Grünberger M: Die kognitive Pupillenoszillationshypothese bei Patienten mit neurologischen Störungen bzw. organischem Psychosyndrom. Reliabilitöt und Validität eines neuen psychophysiologischen Verfahrens. Wiener Klinische Wochenschrift 108: 69-74, 1996
Wilhelm H, Ludtke H, Wilhelm B: Pupillographic sleepiness testing in hypersomniacs and normals. Graefes Arch Clin Exp Ophtalmol 236: 725-729, 1998
Wilhelm B, Wilhelm H, Ludtke H, Streicher P, Adler P: Pupillographic assessment of sleepiness in sleep-deprived healthy subjects. Sleep 21: 258-265, 1998
Ludtke H, Wilhelm B, Adler M, Schaeffel F, Wilhelm H: Mathematical procedures in data recording and processing of pupillary. Vision Res 38: 2889-2896, 1998
Gruenberger J, Linzmayer L: Computer-gesteuerte klinisch-psychodiagnostische Methoden in der Psychiatrie. Neuropsychiatrie 4: 89, 1991
Lehrl S: Der MWT-B (Mehrfachwahl-Wortschatztest) perimed Fachbuch-Verlagsgesellschaft m.b.H. Erlangen, 1989
Gruenberger J: Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychatrie. Maudrich, Vienna, 1997
Benton A: Der Benton Test. 7th edn., Hans Huber, Bern-Göttingen, 1996
Davidson RA, Fedio P, Smith BD, Aureille E, Martin A: Lateralized mediation of arousal and habituation: differential bilateral electrodermal activity in unilateral temporal lobectomy patients. Neuropsychologia 30: 1053-1063, 1992
Lehman AF, Burns BJ: Severe mental illness in the community. In: Spilker B (ed) Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven, Philadelphia, 1996, pp 919-924
Michael YL, Berkman LF, Colditz GA, Holmes MD, Kawachi I: Social networks and health-related quality of life in breast cancer survivors: a prospective study. J Psychosom Res 52: 285-293, 2002
Salander P, Bergenheim T, Henriksson R: The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med 42: 985-996, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidinger, M., Linzmayer, L., Becherer, A. et al. Psychometric- and Quality-of-life Assessment in long-term Glioblastoma survivors. J Neurooncol 63, 55–61 (2003). https://doi.org/10.1023/A:1023740303162
Issue Date:
DOI: https://doi.org/10.1023/A:1023740303162